Next Article in Journal
Nanostructured Materials for Artificial Tissue Replacements
Next Article in Special Issue
Targeting Mitochondrial Network Architecture in Down Syndrome and Aging
Previous Article in Journal
Protective Effects of Recombinant Human Soluble Thrombomodulin on Lipopolysaccharide-Induced Acute Kidney Injury
Previous Article in Special Issue
Pioglitazone and Deoxyribonucleoside Combination Treatment Increases Mitochondrial Respiratory Capacity in m.3243A>G MELAS Cybrid Cells
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Cbs Locus Affects the Expression of Senescence Markers and mtDNA Copy Number, but not Telomere Dynamics in Mice

by
Olga Utyro
1,2,3,
Joanna Perła-Kaján
1 and
Hieronim Jakubowski
1,3,*
1
Department of Biochemistry and Biotechnology, University of Life Sciences, 60-632 Poznań, Poland
2
Institute of Bioorganic Chemistry, Polish Academy of Sciences, 61-704 Poznań, Poland
3
Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers-New Jersey Medical School, International Center for Public Health, Newark, NJ 07-103, USA
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(7), 2520; https://doi.org/10.3390/ijms21072520
Submission received: 4 January 2020 / Revised: 13 March 2020 / Accepted: 1 April 2020 / Published: 5 April 2020
(This article belongs to the Special Issue Targeting Mitochondria in Aging and Disease)

Abstract

:
Cystathionine β-synthase (CBS) is a housekeeping enzyme that catalyzes the first step of the homocysteine to cysteine transsulfuration pathway. Homozygous deletion of the Cbs gene in mice causes severe hyperhomocysteinemia and reduces life span. Here, we examined a possible involvement of senescence, mitochondrial DNA, and telomeres in the reduced life span of Cbs−/− mice. We found that senescence-related p21, Pai-1, Mcp1, and Il-6 mRNAs were significantly upregulated (2–10-fold) in liver, while p21 was upregulated in the brain of Cbs−/− mice (n = 20) compared with control Cbs+/− siblings (n = 20) in a sex- and age-dependent manner. Telomere length in blood (n = 80), liver (n = 40), and brain (n = 40) was not affected by the Cbs−/− genotype, but varied with sex and/or age. Levels of mitochondrial DNA tended to be reduced in livers, but not brains and blood, of Cbs−/− females (n = 20–40). The Cbs−/− genotype significantly reduced Tert mRNA expression in brain, but not liver, in a sex- and age-dependent manner. Multiple regression analysis showed that the senescence-related liver (but not brain) mRNAs and liver (but not brain or blood) mitochondrial DNA were associated with the Cbs genotype. In contrast, telomere length in blood, brain, and liver was not associated with the Cbs genotype or hyperhomocysteinemia, but was associated with sex (in brain and liver) and age (in brain and blood). Taken together, these findings suggest that the changes in senescence marker expression and mtDNA levels, but not telomere shortening, could account for the reduced life span of Cbs−/− mice.

1. Introduction

Cellular senescence irreversibly arrests proliferation and is an important contributor to aging and age-related disease [1]. Senescence results in a loss of tissue repair ability due to stabilization of p53 and upregulation of the downstream p53 targets such as p21 and PAI-1 [2,3], which prevents CDK2-mediated inactivation of RB, thereby preventing entry into the S-phase of the cell cycle [1]. Senescent cells produce the senescence-associated secretory phenotype, i.e., pro-inflammatory and matrix degrading molecules (IL-6, MCP1, PAI-1, etc.). Although well studied in cultured cells in vitro, senescence in vivo in humans and animals is poorly understood [4]. One of the factors that induces the p53-p21 senescence pathway is telomere shortening [1].
Telomeres are tandem DNA repeats of TTAGGG structures at the end of chromosomes important for genomic stability in all vertebrates. The telomere sequence is more sensitive to damage than non-telomeric DNA, and its length progressively shortens with age during somatic cell division. Short telomeres are a feature associated with cellular senescence and death. Telomeres are synthesized by the telomerase (TERT) enzyme, a reverse transcriptase active during early human development, but becoming silenced in somatic cells at 12–18 weeks of gestation [5]. However, mice that have telomeres 50–150-kb long (5–10 times longer than humans, express Tert in somatic cells [6]. TERT activation occurs in 85–90% of all human cancers [7,8]. Short telomeres are usually found in a variety of human diseases that lead to premature death [9]. Thus, telomere length is considered to be a biomarker of aging and a major determinant of aging and the life span [6,10]. Recent findings in a variety of bird and mammalian species show that the telomere shortening rate, but not the telomere length alone, is a predictor of species life span [11]. Several genetic loci, including five known to be involved in telomere biology, are associated with telomere length and with increased risk of age-related diseases in humans [12]. Shorter telomeres are found in men vs. women, in older vs. younger individuals, and in Caucasian vs. other races [13].
Mitochondrial DNA (mtDNA) is an essential multicopy organellar genome organized into protein-DNA structures called nucleoids. The mtDNA lacks histones and is more sensitive to damage than nuclear DNA [14]. Like telomere length (TL), the mtDNA copy number changes with age [15]. A preponderance of evidence indicates that mtDNA is correlated with cellular aging and other age-related disorders such as cancer, diabetes, and neurodegenerative diseases [16,17]. Defects in mtDNA maintenance have been suggested to play a role in the mechanisms of aging [18]. However, a high mtDNA copy number is detrimental and leads to nucleoid enlargement, defective transcription, and age-related accumulation of mtDNA deletions, which causes respiratory chain protein deficiency [19].
Cystathionine β-synthase (CBS) deficiency, a rare metabolic disease caused by mutations in the CBS gene, is characterized by severely elevated levels of homocysteine (Hcy) and its metabolites [20,21,22,23] and pathologies in the cardiovascular, skeletal (osteoporosis), and nervous systems [24,25]. These pathologies are generally associated with aging. CBS−/− patients are mentally retarded and experience thromboembolic events in brain, heart, and peripheral veins and arteries, which contribute to the reduced life span in these individuals [24,25].
Homozygous deletion of the Cbs gene leads to a neonatal lethality phenotype due to liver dysfunction with only a few percent of Cbs−/− pups surviving to adulthood [26]. The creation of transgenic Cbs−/− mice harboring wild-type or mutant versions of the human CBS gene under the control of the zinc-inducible metallothionein promoter prevents the neonatal lethality. One of those variants, the Tg-I278T Cbs−/− mouse, has a median survival time 25% shorter compared to sibling controls (613 vs. 821 days) [27].
Although Cbs deficiency reduces life span, it is not known whether telomere shortening, senescence, and/or mtDNA copy number are involved. For this reason, the present work has been undertaken to study telomere length (TL), mtDNA levels, and Tert and senescence/aging marker (Mcp1, Il-6, Pai-1, p21, and klotho, Kl) mRNA expression in the tissues of severely hyperhomocysteinemic Tg-I278T Cbs−/− mice and their sibling controls.

2. Results

2.1. Cbs Genotype Affects the Expression of Senescence-Related mRNAs in Mice

Tg-I278T Cbs−/− mice have severe hyperhomocysteinemia (HHcy) (plasma total Hcy = 272 ± 50 μM compared to 5.0 ± 2.6 μM in Cbs+/− siblings [28]), a 25% shorter life span (613 vs. 821 days) [27], and are characterized by a thin, smooth, shiny tail [29] and a reduced body weight [29]. Other characteristics of the Tg-I278T Cbs−/− mice include facial alopecia, osteoporosis (rough periosteal surface and small holes in femur, reduced trabecular bone mass, decreased bone mineral density), and endoplasmic reticulum stress in liver and kidney [27]. These phenotypes are generally associated with aging.
We hypothesized that the reduced life span of the Cbs−/− mice could be caused by premature senescence. To examine this hypothesis, we quantified the expression of senescence-related mRNAs (Pai-1, p21, Mcp1, Il-6, p16, and Il-1β) and an aging-related Kl mRNA relative to β-actin and Gapdh mRNAs in mouse brains and livers. We found that Pai-1, p21, Mcp1, and Il-6 mRNAs were significantly upregulated in livers of Cbs−/− mice compared to Cbs+/− siblings (Figure 1A–C,E), while p16 and Il-1β mRNAs were not affected by the Cbs−/− genotype (Figure 1D,F). The expression of the corresponding mRNAs in brains was similar between Cbs−/− mice and their Cbs+/− siblings (not shown).

2.1.1. Liver

We also found that the effects of the Cbs−/− genotype on the expression of senescence-related mRNAs were sex- and age-dependent. In young Cbs−/− female mice, liver p21, Pai-1, and Mcp-1 mRNAs were significantly upregulated (7.6- to 11.0-fold, p = 0.014–0.025) compared to young Cbs+/− females. Liver p21 and Pai-1 mRNAs were also upregulated (4.2- to 4.4-fold, p = 0.006–0.059) in old Cbs−/− females (Supplementary Table S1).
In young Cbs−/− male mice, liver p21, Mcp-1, and Il-6 mRNAs were upregulated (3.0- to 8.7-fold, p = 0.005–0.063) compared to young Cbs+/− males. Liver Mcp-1 mRNA was also upregulated (3.2-fold, p = 0.034) in old Cbs−/− males (Supplementary Table S1).
Sex significantly affected the expression of liver Mcp-1 (lower in Cbs−/− males, p = 0.004) and Il-6 mRNAs (higher in Cbs+/− males, p = 0.010) (Supplementary Table S1).
In Cbs−/− mice, age significantly affected the expression of liver Pai-1 (lower in old Cbs−/− females, p = 0.004) and Mcp-1 mRNAs (higher in old Cbs−/− males, p = 0.034). In Cbs+/− mice, age affected the expression of liver Mcp-1, Il-6 (higher in old Cbs+/- females and males) and p21 mRNAs (higher in old Cbs+/- females) (Supplementary Table S1).
Although the Cbs genotype had no effect on Il-1β and p16 mRNAs in the whole mouse cohort (Figure 1D,F), subgroup analyses showed that p16 mRNA was downregulated in young and old female Cbs−/− mice relative to Cbs+/− females (young: 0.04 vs. 0.15, p = 0.035; old: 6.5 vs. 14.1, p = 0.046), but not in males. Il-1β mRNA was not affected by the Cbs genotype in any of the age and sex subgroups. Il-1β mRNA was significantly upregulated in old mice, similarly in Cbs−/− and Cbs+/− females and males (2.5- to five-fold; p = 0.015–0.039).

2.1.2. Brain

The expression of senescence-related brain p21, Mcp-1, Pai-1, and Il-6 mRNAs appeared to be unaffected by the Cbs−/− genotype in the whole mouse cohort, as was Kl mRNA (not shown). However, examination of sex and age subgroups revealed that, in Cbs−/− female mice, brain p21 and Mcp-1 mRNAs were significantly upregulated relative to Cbs+/− females (1.9-fold in young, p = 0.035, and 1.4-fold in old females, p = 0.020, respectively; Supplementary Table S2). However, the expression of the senescence-related brain mRNAs was unaffected by the Cbs−/− genotype in males.
Sex significantly affected the expression of brain p21, Mcp-1, Il-6, and Kl mRNAs in Cbs−/− mice, (1.4- to 2.5-fold higher in females than in males, p = 0.040 to 0.004). In Cbs+/− mice, sex affected the expression of brain p21 in old mice (2.1-fold higher in females, p = 0.036) and Mcp-1 mRNAs (lower in females, p = 0.052; Supplementary Table S2).
Age significantly affected the expression of brain Mcp-1 (1.6-fold higher in old vs. young Cbs−/− females, p = 0.020), Kl (0.6-fold lower in old Cbs−/− females, p = 0.022), and p21 (0.5-fold lower in old vs. young Cbs+/− males, p = 0.038) mRNAs (Supplementary Table S2).
Brain Il-1β and p16 mRNAs were not affected by the Cbs genotype in any of the age and sex subgroups. Age and sex did not affect brain Il-1β mRNA, while age significantly affected brain p16 mRNA (six- to 10-fold higher in old vs. young mice, p = 0.009 to 0.000).

2.2. Cbs Genotype and TL

2.2.1. Blood TL

We quantified TL in the blood of Cbs−/− mice (n = 40) and their Cbs+/− siblings (n = 40) and found that blood TL was not affected by the Cbs genotype (Figure 2A). In males, blood TL decreased with age over the span from 36 to 473 days, similarly in both Cbs−/− mice and their Cbs+/− siblings (Supplementary Figure S1A). In females, blood TL was also similar between Cbs−/− and Cbs+/− mice, and there was little change in blood TL with age (Supplementary Figure S1B). Blood TL tended to decrease with increasing plasma tHcy in male, but not in female mice (Supplementary Figure S1C).
Further analyses showed that blood TL was similar between Cbs−/− and Cbs+/− young females (1.08 ± 0.31 vs. 1.12 ± 0.41, p = 0.820) and males (1.19 ± 0.27 vs. 1.34 ± 0.27, p = 0.335). Blood TL was also similar between old Cbs−/− and Cbs+/− mice of both sexes (females: 1.10 ± 0.19 and 1.01 ± 0.18, p = 0.182; males: 0.68 ± 0.17 and 0.64 ± 0.19, p = 0.615) (Supplementary Table S3).
Total Hcy levels were severely elevated in Cbs−/− compared to Cbs+/− mice (166 ± 80 μM vs. 6.6 ± 2.9 μM, p < 0.000) (Figure 2B), as expected [27,28]. Levels of tHcy increased with age in Cbs−/− females (238 ± 33 vs. 133 ± 64 μM, p = 0.002), but not in males, and were significantly higher in females compared with males (238 ± 33 vs. 156 ± 96 μM, p = 0.044) (Supplementary Table S3). Notably, in the whole mouse cohort (Figure 1A) and in sex- and age-stratified groups (Supplementary Table S3), blood TL was not significantly different between severely HHcy Cbs−/− mice compared to Cbs+/− siblings, which had normal tHcy levels.

Effects of Age on Blood TL in Cbs+/− and Cbs−/− Mice

In male Cbs−/− mice, blood TL was significantly reduced in older compared to younger animals (0.68 ± 0.17 vs. 1.19 ± 0.27, p < 0.000) (Supplementary Table S3). Similar reductions in older vs. younger mice were also observed in Cbs+/− males (0.64 ± 0.19 vs. 1.34 ± 0.27, p < 0.000) (Supplementary Table S3). In contrast, in female Cbs−/− and Cbs+/− mice, age did not affect blood TL (Supplementary Table S3).

Effects of Sex on Blood TL in Cbs+/− and Cbs−/− Mice

The effect of sex on blood TL was similar between Cbs+/− and Cbs−/− mice. Specifically, blood TL was significantly higher in old Cbs+/− and Cbs−/− females compared with old males (Cbs+/−: 1.01 ± 0.18 vs. 0.64 ± 0.19, p < 0.000; Cbs−/−: 1.10 ± 0.19 vs. 0.68 ± 0.17, p < 0.000) (Supplementary Table S3). However, this sex-specific difference in TL was absent in young Cbs+/− and Cbs−/− mice.

2.2.2. Brain TL and Tert mRNA

To examine whether Cbs genotype affects TL in a tissue-specific manner, we isolated DNA from brains and livers of Cbs−/− mice (n = 19) and their Cbs+/− siblings (n = 24) and quantified brain and liver TL. To examine whether TL is affected by telomerase expression, we isolated RNA and examined Tert mRNA levels in these tissues.
We found that brain TL was not affected by the Cbs genotype (Supplementary Figure S2A). However, brain TL was affected by sex in a Cbs genotype- and an age-dependent manner. Specifically, in old, but not young, Cbs−/− mice, brain telomeres were significantly longer in males compared to females (1.53 ± 0.34 vs. 0.95 ± 0.22, p = 0.010). In contrast, in young and old Cbs+/− mice, brain TL was not affected by sex and was similar between males and females (Supplementary Table S4).
We also found that brain Tert mRNA expression was not affected by the Cbs genotype in the whole mouse cohort (Supplementary Figure S3A). However, Tert mRNA appeared to be affected by the Cbs genotype in some age-and sex-stratified subgroups. Specifically, young, but not old, Cbs−/− male, but not female, mice had significantly reduced expression of brain Tert mRNA compared to Cbs+/− animals (0.55 ± 0.17 vs. 1.26 ± 0.39, p = 0.035) (Supplementary Table S4).
Brain Tert mRNA expression was also affected by sex. Specifically, in young Cbs−/− mice, brain Tert mRNA was significantly elevated in females compared to males (1.29 ± 0.33 vs. 0.55 ± 0.17, p = 0.017) (Supplementary Table S4). In old Cbs+/− mice, brain Tert mRNA tended to be reduced in males compared to females (0.66 ± 0.21 vs. 1.28 ± 0.61, p = 0.067).
Brain Tert mRNA expression was also affected by age in a sex-dependent manner. Specifically, brain Tert mRNA levels were significantly reduced in old compared to young male (0.66 ± 0.21 vs. 1.26 ± 0.39, p = 0.022), but not female, Cbs+/− mice; however, this effect of age was absent in Cbs−/− mice (Supplementary Table S4).

2.2.3. Liver TL and Tert mRNA

Liver TL, similar to blood TL (Figure 2, Supplementary Table S3) and brain TL (Supplementary Figure S2A), was not affected by the Cbs genotype (Supplementary Figure S2B). However, liver TL was affected by sex in an age-dependent manner. For example, in old mice, liver TL were significantly longer in females compared to males, both in Cbs−/− (1.11 ± 0.30 vs. 0.75 ± 0.19, p = 0.014) and Cbs+/− mice (1.50 ± 0.58 vs. 0.78 ± 0.23, p = 0.018) (Supplementary Table S5). In contrast, in young Cbs−/− and Cbs+/− mice, there was no significant difference in liver TL between females and males (Supplementary Table S5).
Similar to brain TL (Supplementary Table S4), but in contrast to blood TL (Figure 2, Supplementary Table S3), liver TL was not affected by age in Cbs−/− and Cbs+/− mice (Supplementary Table S5).
Liver Tert mRNA expression was also similar between Cbs−/− and Cbs+/− mice (Supplementary Figure S3B), but was affected by sex in a Cbs genotype- and age-dependent manner. Specifically, in young Cbs−/− mice, liver Tert mRNA was lower in females compared to males (0.22 ± 0.10 vs. 0.43 ± 0.03, p = 0.020) (Supplementary Table S5). In old Cbs−/− mice, liver Tert mRNA expression was lower in females compared to males (2.22 ± 0.21 vs. 1.43 ± 0.47, p = 0.029). In old Cbs+/− mice, liver Tert mRNA was higher in females compared to males (2.89 ± 1.07 vs. 1.43 ± 0.39, p = 0.012) (Supplementary Table S5).

2.3. Cbs Genotype and mtDNA Copy Number in Blood, Liver, and Brain

In the whole mouse cohort, blood, liver, and brain mtDNA levels were not affected by the Cbs genotype (Supplementary Figure S4). However, mtDNA was affected by age and sex (see below).

2.3.1. Blood mtDNA

Relationships between blood mtDNA and age for Cbs−/− and Cbs+/− mice of each sex are shown in Figure 3. Overall, blood mtDNA decreased with age over the span from 36 to 390 days, similarly for Cbs−/− and Cbs+/− mice and for both females and males.
Further analyses showed that blood mtDNA was not affected by the Cbs genotype, but was affected by sex and age: higher in young compared with old female Cbs−/− (1.39 ± 0.78 vs. 0.68 ± 0.13, p = 0.004) and Cbs+/− (1.46 ± 0.72 vs. 0.84 ± 0.75, p = 0.103) mice. mtDNA was also higher in young vs. old male Cbs−/− (1.51 ± 1.09 vs. 0.76 ± 0.40, p = 0.046) and Cbs+/− (2.15 ± 0.96 vs. 0.87 ± 0.62, p = 0.003) mice (Supplementary Table S6).
Blood mtDNA was also affected by sex in young, but not old, Cbs+/− mice: higher in young males compared with young females (2.15 ± 0.96 vs. 1.46 ± 0.72, p = 0.041). This sex effect was abrogated by the Cbs−/− genotype (1.51 ± 1.09 vs. 1.39 ± 0.78, p = 0.322) (Supplementary Table S6).

2.3.2. Brain and Liver mtDNA

Liver mtDNA tended to decrease in Cbs−/− mice compared to Cbs+/− animals (1.12 ± 0.49 vs. 1.75 ± 0.53, p = 0.059), while brain mtDNA was not affected by the Cbs genotype (Supplementary Table S6).
We found that brain and liver mtDNAs were affected by sex (higher in males) and age (Supplementary Table S6). However, in contrast to blood mtDNA, which decreased with age, mtDNA significantly increased in brains of old compared to young Cbs−/− males (1.31±0.23 vs. 0.95 ± 0.14, p = 0.002) and Cbs+/− males (1.40 ± 0.60 vs. 0.89 ± 0.13, p = 0.048). Increased mtDNA levels were also found in livers of old compared to young Cbs−/− and Cbs+/− mice of both sexes.

2.4. Determinants of Blood TL in Mice

Associations between blood TL and independent variables are shown in Table 1 and Table 2. Pearson correlation analyses of a whole cohort including Cbs−/− and Cbs+/− mice showed that blood TL was significantly associated with age, but not with the Cbs genotype or tHcy (Table 1).
Multiple regression analysis for the whole cohort including Cbs−/− and Cbs+/− mice of both sexes showed that blood TL was not associated with the Cbs genotype, plasma tHcy, age, or sex (Table 1). However, in male mice, blood TL was negatively associated with age, which explained 18–34% of the TL variation (Table 1).

2.5. Determinants of TL in Mouse Brain and Liver

Comparative multiple regression analysis of determinants of blood TL, brain TL, and liver TL is shown in Table 2. Similar to blood TL, brain and liver TL were also found not to be associated with the Cbs genotype. However, in contrast to blood TL, brain TL was associated with sex and age, while liver TL was associated with sex, explaining 39% and 26% of the TL variation in brain and liver, respectively (Table 2).

2.6. Determinants of Tert mRNA Expression in Mouse Brain and Liver

Multiple regression analysis in a model involving sex, age, the Cbs genotype, and TL showed that the brain and liver Tert mRNAs were not associated with the Cbs genotype (Supplementary Table S7). However, brain Tert mRNA expression was associated with sex (Supplementary Table S7), young Cbs−/− female mice having higher expression than males (1.29 ± 0.33 vs. 0.55 ± 0.17, p = 0.017, Supplementary Table S4), explaining 28% of the variability in Tert mRNA (Supplementary Table S7). Liver Tert mRNA was positively associated with TL and age, which explained 69% variability in Tert mRNA expression (Supplementary Table S7).

2.7. Determinants of Blood, Brain, and Liver mtDNA

2.7.1. Pearson Correlations

Pearson correlation analysis of the whole cohort including Cbs−/− and Cbs+/− mice of both sexes showed that blood mtDNA was associated with the Cbs genotype (p = 0.044), sex (p = 0.021), and age (p = 0.025) (Table 3). Brain mtDNA was associated with sex (p = 0.007) and age (p = 0.005). Liver mtDNA was associated with age.
Pearson correlation analysis stratified by sex showed that blood mtDNA was significantly associated with the Cbs genotype (p = 0.014) and age (p = 0.005) in males. Brain and liver TL were associated with age in males and females.

2.7.2. Multiple Regression

In multiple regression analysis for the whole mouse cohort in models including sex, age, and the Cbs genotype or plasma tHcy, liver mtDNA was significantly associated with the Cbs genotype (β = 0.24, p = 0.041) and age (β = 0.70, p = 0.000) in the whole mouse cohort including both sexes. The association with the Cbs genotype was somewhat stronger in the female subgroup (β = 0.35, p = 0.030). In contrast, in the male subgroup, age (p = 0.003), but not the Cbs genotype, was the only significant determinant of liver mtDNA. The Cbs genotype and age explained 44% of the liver mtDNA variability in the whole cohort and 63 % in the female subgroup (Table 3).
In contrast, brain and blood mtDNAs were not associated with the Cbs genotype, but were associated with sex and age, which explained 35% (brain) and 24–29% (blood) of the mtDNA variability (Table 3). Brain mtDNA was also significantly associated with age in the female (β = 0.49, p = 0.023) and male (β = 0.49, p = 0.032) subgroups.
Multiple regression analysis of subgroups in models involving age and the Cbs genotype or plasma tHcy showed that most of the blood mtDNA variability occurred in males (R2 = 0.35–0.48), not females (R2 = 0.01–0.1). The blood mtDNA was strongly associated with age in males (β = −0.58, p = 0.000) and tended to be associated with the Cbs genotype (p = 0.058), but not plasma tHcy (p = 0.419). Age and the Cbs genotype explained 48% of the variability in mtDNA in males (Table 3).

2.8. Determinants of Senescence-Related mRNAs in Mice

Associations between senescence-related mRNAs and independent variables in mouse brain and liver are presented in Table 4.

2.8.1. Liver

Multiple regression analysis for the whole cohort of mice in models including sex, age, the Cbs genotype, TL, Tert mRNA, and mtDNA showed that the Cbs genotype was the strongest determinant of the liver Pai-1, p21, and Mcp1 mRNAs (p = 0.001), while liver mtDNA was the strongest determinant of liver Il-6 (p = 0.000, Table 4) and Il-1β mRNAs (p = 0.000, Table 5).
Multiple regression analysis for the female mice subgroup showed that the Cbs−/− genotype was the strongest positive determinant of liver Pai-1, p21, Mcp1, and Il-6 mRNAs (p = 0.021–0.007). In addition, Tert mRNA (p = 0.002–0.006) was a positive determinant of liver Pai-1, Mcp1, and Il-6 mRNAs, while liver mtDNA (p = 0.002) was a positive determinant of liver Pai-1 and Il-6 mRNAs in females (Table 4). The Cbs genotype tended to be associated with liver p16 mRNA (p = 0.086, Table 5).
In the male mice subgroup, the Cbs−/− genotype was a significant positive determinant of liver p21 (p = 0.034) and Mcp1 (p = 0.013) mRNAs. In addition, liver Tert mRNA (p = 0.020) and age (p = 0.002) were positive determinants of liver Pai-1 and Mcp1 mRNAs, respectively; liver Tert mRNA (p = 0.016) was a negative determinant, while liver mtDNA (p = 0.001) and age (p = 0.015) were positive determinants of liver Il-6 mRNA (Table 4).

2.8.2. Brain

Multiple regression analysis for the whole cohort of mice showed that the Cbs genotype was not a determinant of any senescence-related mRNAs in brain (Table 4).
However, multiple regression analysis identified other brain variables as significant positive determinants of brain senescence-related mRNAs: mtDNA (p = 0.018) of Pai-1 mRNA, sex (p = 0.044), and TL (p = 0.028) of p21 mRNA (higher in females) and age (p = 0.008) and Tert mRNA (p = 0.019) of Il-6 and Kl mRNAs, respectively (Table 4). Age and sex were determinants of p16 mRNA (p = 0.001, Table 5).
In multiple regression analysis for sex subgroups, age was a positive determinant of brain Mcp1 and Il-6 mRNAs in male mice and a negative determinant of brain Kl mRNA in female mice (Table 4). The Cbs genotype tended to be associated with brain p16 mRNA (p = 0.065, Table 5).

3. Discussion

Cbs deficiency has been known to reduce life span both in humans and mice. However, the underlying mechanism of the reduced life span in Cbs deficiency was unknown. In the present work, we examined a possible involvement of telomere shortening, mtDNA copy number, and accelerated senescence in the reduced life span of Cbs−/− mice.
We used a Cbs−/− mouse model that recapitulated the reduced life span and pathological phenotypes generally associated with aging observed in CBS-deficient patients. We found that the expression of senescence-associated mRNAs (two targets of p53: Pai-1 and p21; and three components of the senescence-associated secretory phenotype: Mcp-1, Pai-1, and Il-6) were significantly upregulated in livers of Cbs−/− mice compared to control Cbs+/− siblings (Figure 1). However, the expression of liver p16 and Il-1β and the antiaging Kl protein mRNAs was not affected by the Cbs genotype. These expression patterns were specific to liver and the Cbs−/− genotype had no effect on the expression of any of these mRNAs in brain. It should be noted that p16 mRNA, which is considered to be a more specific marker for senescence, is not expressed by all senescent cells [30] and is expressed in certain non-senescent cells [31]. The senescence phenotype is known to be variable [4,30,31], and our findings in Cbs−/− mice provided another example of such variability.
The present findings suggested that accelerated senescence could provide a plausible molecular mechanism contributing to hepatic steatosis observed in Cbs−/− mice [26,27,32]. Importantly, our findings also suggested that accelerated senescence in liver could also explained the reduced life span associated with Cbs deficiency in mice.
We found that the Cbs genotype and HHcy did not affect TL in blood (Figure 2), brain, and liver (Supplementary Figure S2). We also found that Tert mRNA expression was not associated with the Cbs genotype, but was associated with TL in liver and not in brain. The lack of association of TL with the Cbs genotype suggested that the reduced life span in Cbs−/− mice was caused by accelerated senescence in liver and was unlikely to be mediated by HHcy or telomere shortening.
Although we found no association between the Cbs genotype and TL in any of the threes mouse tissues that were examined, we did find that age and sex, known to affect TL in other biological systems [4,5], were associated with TL in our mouse cohort (Table 1 and Table 2). For example, blood TL was associated with age in male mice and brain TL with sex and age, while liver TL was associated with sex. These effects of age/sex on TL provided positive controls and indicated that our assays were sufficiently sensitive to allow identification of variables known to be associated with TL, thereby increasing confidence in the present findings.
We also found that the Cbs genotype was a significant determinant of liver mtDNA copy number (Table 3). Specifically, liver mtDNA copy number was reduced in Cbs−/− mice compared with Cbs+/− sibling controls, suggesting the involvement of hepatic respiratory chain deficiency in the reduced life span of Cbs−/− mice. In contrast, the Cbs genotype did not affect the brain mtDNA copy number, showing that the Cbs−/− genotype-induced reduction in mtDNA copy number was liver specific. Because mtDNA copy number is essential for maintaining oxidative capacity, ATP generation, and ultimately cell survival, our findings suggested that reduced liver mtDNA copy number could be responsible for the reduced life span in Cbs−/− mice.
Our findings also showed that mtDNA copy number in Cbs−/− and Cbs+/− mice changed with age in a tissue-dependent manner: decreases in blood and increases in brain and liver (Table 3; Supplementary Table S6). Similar tissue-dependent changes have been previously reported in aging wild-type mice [15,33] and rats [34] by other investigators. It should be noted, however, that both decreased and increased copy number of mtDNA can cause mitochondrial dysfunction [19]. In fact, increased mtDNA copy number is found in human patients with bipolar disorder, which is associated with accelerated aging [35]. However, similar to the present findings in Cbs-deficient mice, TL was not affected in the bipolar disorder patients.
The limitations of this study should be noted. First, we did not study the expression of senescence-associated genes at the protein level. Measuring senescence-related protein levels in the mouse (e.g., p16) can be challenging mostly due to the availability of antibodies [36]. However, as regulation of these genes occurs at the transcriptional level [4,30,31], one can expect to observe similar changes at the protein level caused by the Cbs genotype. Second, we did not have tissues suitable for immunohistochemistry of markers such as senescence-associated β-galactosidase (SA-β-gal). However, although SA-β-gal is prominent in senescent sells, it is neither required, nor a determinant of the senescence phenotype [4,37]. Third, although the number of Cbs−/− and Cbs−/− mice was 20 to 40 per each Cbs genotype group, the number of animals in the sex- and age-stratified subgroups was accordingly much lower. However, despite the relatively low number of animals in these subgroups, we found that age and sex, which are known to affect TL [13,15], were associated with TL in the present study (Table 1 and Table 2). We also found that age, known to affect mtDNA copy number in wild-type mice [15,33] and rats [34], was associated with mtDNA in the present study (Figure 3 and Table 3).
In conclusion, we showed that Cbs−/− mice had significantly upregulated expression of some senescence-related mRNAs (Pai-1, p21, Mcp-1, and Il-6) in liver, but not in brain, and reduced mtDNA copy number in liver, but not in brain and blood. We also showed that TL in any of those tissues was not affected by the Cbs−/− genotype. These findings suggested that accelerated senescence, mostly affecting liver, and impaired mitochondrial function, but not telomere shortening, could contribute to the reduced life span of Cbs−/− mice.

4. Materials and Methods

4.1. Mice

Transgenic Tg-I278T Cbs−/− mice on a C57BL/6J genetic background [27] were mated with their Tg-I278T Cbs+/- counterparts to generate sufficient numbers of Tg-I278T Cbs−/− and Tg-I278T Cbs+/− animals required for the experiments. The mice were bred and housed at the New Jersey Medical School Animal Facility [29,38]. In these animals, the human CBS-I278T variant was under the control of the zinc-inducible metallothionein promoter, which prevents the neonatal lethality of the mouse Cbs−/− genotype by supplementation of the drinking water with 25 mM ZnCl2 [27]. The zinc water was replaced by plain water after weaning at 30 days. The mice were fed a normal rodent chow (LabDiet5010, Purina Mills International, St. Louis, MO, USA). The Cbs genotype was established by PCR using the following primers: forward 5’-GGTCTGGAATTCACTATGTAGC-3’, Cbs- reverse 5’- GAGGTCGACGGTATCGATA-3’ (affording a 176 bp product), Cbs+ reverse 5’-CGGATGACCTGCATTCATCT-3’ (affording a 300 bp product). Mice (n = 40 to 80) of both sexes, 63 to 408 days old, were used in experiments. Animal procedures were approved by the Institutional Animal Care and Use Committee at the New Jersey Medical School.

4.2. Blood and Tissue Collection

Blood was collected from cheek veins into Eppendorf tubes containing 1% (v/v) 0.5 M EDTA. After centrifugation (2000× g, 10 min, 4 °C), separated plasma and cells were frozen at −80 °C. Mice were euthanized using CO2 and the organs collected and frozen on dry ice. Brains and livers were powdered with dry ice using a mortar and pestle and stored at −80 °C.

4.3. Total Hcy Assays

Plasma tHcy was quantified by the conversion to Hcy-thiolactone, which was then separated by cation exchange HPLC using a Poly CAT A column, 35 × 2.1 mm, 5 µM, 300 Å (PolyLC), post-column derivatized with o-phthalaldehyde, detected and quantified by fluorescence as previously described [28,39]. An Agilent Infinity 1260 system, containing a degasser, binary pump, high performance auto-sampler, thermostated column compartment, and fluorescence detector, was used.

4.4. DNA Extraction

Total DNA, extracted from brain, liver, or whole mouse blood using the phenol method, was treated with RNase A (Thermo Scientific, Warsaw, Poland) and diluted with ultrapure water. The integrity and quality of the DNA were tested by agarose gel electrophoresis and spectroscopy (Thermo Scientific, Warsaw, Poland).

4.5. Telomere Length Analysis

Mouse genomic DNA was extracted from the whole blood using the phenol extraction method and stored at −80 °C. The telomere length assays were performed using the quantitative polymerase chain reaction (PCR) method to measure telomere length relative to standard reference DNA (T/S ratio), as described in detail elsewhere [40,41]. The telomeres were amplified using primers specific for the telomere repeats (forward: 5’-ACACTAA(GGTTTG)4GGTTAGTGT-3’; reverse 5’-TGTTAGG-(TATCCC)5TAACA-3’). The amplification of the single copy gene albumin (forward: 5’-CGGCG-GCGGGCGGCGCGGGCTGGGCGGAAGTGCTGTAGTGGATCC-CTG-3’; reverse: 5’-GCCCGGCC-CGCCGCGCCCGTCCCGCCGGAGAAGCATGGCCGCCTTT-3’) was used as a control for the input DNA [40,41].
The master mix for each PCR amplification tube was prepared with iTaq™ Universal SYBR® Green Supermix (Bio-Rad Polska Sp. z o.o., Warsaw, Poland), 900 nM of telomere- or albumin-specific primers, and 160 ng DNA as a template. The optimized thermal cycling profile for each reaction mixture was as follows: Step 1: 94 °C for 15 min.; Step 2: 94 °C for 15 s, 49 °C for 15 s, two cycles; Step 3: 94 °C for 15 s, 62 °C for 10 s, 74 °C for 15 s with signal acquisition, 84 °C for 10 s, 88 °C 15 s with signal acquisition, 35 cycles; Step 4: 65–95 °C with signal acquisition (melting curve analysis). The 74 °C reads provided the cycle threshold (Ct) values for the amplification of the telomere template, and the 88 °C reads provided the Ct values for the amplification of the albumin. All qPCRs were carried out on a CFX96 Touch™ Real-Time PCR Detection System (Bio-Rad Polska Sp. Z o.o.).
The relative telomere length (TL) was calculated from the Ct values as the ratio of the telomere signal to the single copy albumin gene signal (T/S ratio) [40,41]. To calculate ΔCt, the Ct for the single-copy albumin gene was subtracted from the telomere Ct (ΔCt = CttelomereCtalbumin). To calculate ΔΔCt, the ΔCt for the DNA from control Cbs+/− individuals was averaged and subtracted from the ΔCt for the DNA from each Cbs−/− mouse and Cbs+/− control animal (ΔΔCt = ΔCtCbs−/− − ΔCtCbs+/−). The T/S values were calculated according to the T/S = 2−(ΔΔCt) equation [42]. Each sample was measured in duplicate. The reproducibility of the measurements was 6%.

4.6. mtDNA Quantification

DNA was diluted with ultrapure water and sonicated in an ultrasonic bath (45 kHz, 5 min) prior to qPCR analysis [43]. The mtDNA was amplified using the following primers: forward 5’-CTAGAAACCCCGAAACCAAA-3’, reverse 5’-CCA-GCTATCACCAAGCTCGT-3’. The amplification of the single copy nuclear gene β2 microglobulin (B2M) (forward 5’-ATGGGAAGCCGAACATACTG-3’, reverse 5’-CAGTCTCAGTGGGGGTGAAT-3’) was used for normalization of mtDNA.
All reactions were performed in 10 µL volumes in duplicate using 20 ng DNA, 3 µM primers, and 5 µL iTaq Universal SYBR Green Supermix (Bio-Rad Polska Sp.z o.o.) using a CFX96 Touch Real Time PCR Detection System (Bio-Rad). Cycling parameters: 95 °C (10 min), 40 cycles at 95 °C (15 s), 60 °C (10 s), and 72 °C (15 s). The homogeneity of qPCR products was confirmed by melting curve analysis (65 °C and a progressive increase up to 95 °C at 0.5 °C/min). Analysis of the data was performed with the CFX Manager™ Software and Microsoft Excel. Calculations were similar as those for telomere length above [42].

4.7. RNA Extraction

Total RNA was extracted using a column-based Total RNA Purification Kit (Novazym, Poznań, Poland). Three-zone reagent was added to the frozen powdered brain or liver tissue. After the extraction step, the supernatant was mixed with 70% ethanol, loaded onto a total RNA miniprep column, washed with 70% ethanol, and eluted with ultrapure water. The RNA was DNase treated using the DNase I (Thermo Scientific, Warsaw, Poland). The integrity and quality of the RNA were confirmed by agarose gel electrophoresis and spectroscopy (Thermo Scientific, Warsaw, Poland).

4.8. Quantification of Tert and Senescence-Related mRNAs by Real-Time qPCR

cDNA synthesis was carried out in reaction mixtures (20 µL) containing 1 μg of total RNA, RivertAid H Reverse Transcriptase (Thermo Scientific, Warsaw, Poland), and oligo(dT)23 (Sigma-Aldrich, Sp z o.o., Poznań, Poland) (42 °C, 60 min and 70 °C, 10 min).
qPCR analyses were carried out in duplicate reaction mixtures (10 µL) containing 20 ng (for Tert) or 40 ng (for senescence markers) cDNA, 0.3 µM primers (Supplementary Table S8), and 5 µL iTaq Universal SYBR Green Supermix (Bio-Rad Polska Sp. z o.o.) using a CFX96 Touch Real Time PCR Detection System (Bio-Rad). Cycling parameters were: 95 °C (2 min), 40 cycles at 95 °C (15 s), 60 °C (15 s), and 72 °C (15 s). Following qPCR, the homogeneity of the products was confirmed by melting curve analysis (60 °C and a progressive increase up to 95 °C at 0.5 °C/min). Mouse mRNAs for Tert, senescence markers (p21, Il-6, Pai-1, Mcp1), and the anti-aging protein Klotho (Kl) were normalized to β-actin and Gapdh mRNAs. Data analysis was performed with the CFX Manager™ Software, Microsoft Excel, and Statistica. The 2(−ΔΔCt) method was used to calculate relative expression values [42].

4.9. Statistical Analyses

Data are expressed as the means ± SEM (Figure 1 and Figure 2) and the means ± SD (Supplementary Tables S1–S6). Comparisons between groups were analyzed using an unpaired 2-sided t-test. Associations between telomere length and other variables were analyzed by Pearson’s correlations and linear regression. The interaction effects of age, gender, tHcy, or the CBS genotype on TL and mtDNA were examined by analysis of covariance and/or multiple regression models where appropriate. Statistical analysis was performed using Statistica, Version 13 (TIBCO Software Inc., Palo Alto, CA, USA, http://statistica.io).

Supplementary Materials

Supplementary materials can be found at https://www.mdpi.com/1422-0067/21/7/2520/s1. Figure S1. Relationships between blood TL, age, and tHcy in Cbs−/− and Cbs + /− mice. Blood TL vs. age in (A) female and (B) male mice. (C) Blood TL vs. tHcy; Figure S2. Telomere length (TL) in brains (A) and livers (B) of Cbs−/− and Cbs+/− mice. TL was quantified by qPCR in Cbs−/− mice (n = 21) and sex- and age-matched control Cbs+/− siblings (n = 22) as described in the Materials and Methods. Box and whiskers represent the mean ± SEM and the mean ± 95% CI, respectively; Figure S3. Tert mRNA levels in brains (A) and livers (B) of Cbs−/− and Cbs+/− mice. Tert mRNA was quantified by qPCR in Cbs−/− mice (n = 21) and sex- and age-matched control Cbs+/− siblings (n = 22) as described in the Materials and Methods. Box and whiskers represent the mean ± SEM and the mean ± 95% CI, respectively; Figure S4. mtDNA levels in blood (A), livers (B), and brains (C) of Cbs−/− and Cbs+/− mice. mtDNA was quantified by qPCR in Cbs−/− mice (blood, n = 40; liver and brain, n = 21) and sex- and age-matched control Cbs+/− siblings (blood, n = 40; liver and brain, n = 22) as described in the Materials and Methods. Box and whiskers represent the mean ± SEM and the mean ± 95% CI, respectively; Table S1. Aging/senescence-related mRNAs in the liver of Cbs−/− and Cbs+/− mice stratified by sex and age; Table S2. Aging/senescence-related mRNAs in the brain of Cbs−/− and Cbs+/- mice stratified by sex and age; Table S3. Blood TL, plasma tHcy levels in Cbs−/− and Cbs+/− mice stratified by sex and age; Table S4. Brain TL and Tert mRNA expression in Cbs−/− and Cbs+/− mice stratified by sex and age; Table S5. Liver TL and Tert mRNA expression in Cbs−/− and Cbs+/− mice stratified by sex and age; Table S6. mtDNA levels in the blood, brain, and liver of Cbs−/− and Cbs+/− mice stratified by sex and age; Table S7. Determinants of Tert mRNA in the brain and liver of Cbs−/− and Cbs+/− mice: Multiple regression analysis; Table S8. List of primers used for mouse mRNA quantification by RT-qPCR.

Author Contributions

Conceptualization, H.J.; methodology, O.U., J.P.-K., and H.J.; validation, O.U. and H.J.; formal analysis, H.J.; investigation, O.U. and H.J.; resources, H.J.; data curation, O.U. and H.J.; writing, original draft preparation, H.J.; writing, review and editing, O.U., J.P.-K., and H.J.; supervision, H.J.; project administration, H.J.; funding acquisition, O.U., J.P.-K., and H.J. All authors have read and agreed to the published version of the manuscript.

Funding

Supported by grants from the National Science Center, Poland (O.U.: 2015/17/N/NZ3/03626; J.P.K.: 2014/15/B/NZ2/01079; H.J.: 2016/23/B/NZ5/00573, 2018/29/B/NZ4/0071, 2019/33/B/NZ4/01760) and the American Heart Association (H.J.: 17GRNT32910002).

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; nor in the decision to publish the results.

References

  1. Childs, B.G.; Durik, M.; Baker, D.J.; van Deursen, J.M. Cellular senescence in aging and age-related disease: From mechanisms to therapy. Nat. Med. 2015, 21, 1424–1435. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Vaughan, D.E.; Rai, R.; Khan, S.S.; Eren, M.; Ghosh, A.K. Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of Senescence. Arterioscler. Thromb. Vasc. Biol. 2017, 37, 1446–1452. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Khan, S.S.; Shah, S.J.; Klyachko, E.; Baldridge, A.S.; Eren, M.; Place, A.T.; Aviv, A.; Puterman, E.; Lloyd-Jones, D.M.; Heiman, M.; et al. A null mutation in SERPINE1 protects against biological aging in humans. Sci. Adv. 2017, 3, eaao1617. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Gorgoulis, V.; Adams, P.D.; Alimonti, A.; Bennett, D.C.; Bischof, O.; Bishop, C.; Campisi, J.; Collado, M.; Evangelou, K.; Ferbeyre, G.; et al. Cellular Senescence: Defining a Path Forward. Cell 2019, 179, 813–827. [Google Scholar] [CrossRef]
  5. Shay, J.W.; Wright, W.E. Telomeres and telomerase: Three decades of progress. Nat. Rev. Genet. 2019, 20, 299–309. [Google Scholar] [CrossRef]
  6. Calado, R.T.; Dumitriu, B. Telomere dynamics in mice and humans. Semin. Hematol. 2013, 50, 165–174. [Google Scholar] [CrossRef] [Green Version]
  7. Kim, N.W.; Piatyszek, M.A.; Prowse, K.R.; Harley, C.B.; West, M.D.; Ho, P.L.; Coviello, G.M.; Wright, W.E.; Weinrich, S.L.; Shay, J.W. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266, 2011–2015. [Google Scholar] [CrossRef]
  8. Shay, J.W.; Bacchetti, S. A survey of telomerase activity in human cancer. Eur. J. Cancer 1997, 33, 787–791. [Google Scholar] [CrossRef]
  9. Cawthon, R.M.; Smith, K.R.; O’Brien, E.; Sivatchenko, A.; Kerber, R.A. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003, 361, 393–395. [Google Scholar] [CrossRef]
  10. Sanders, J.L.; Boudreau, R.M.; Penninx, B.W.; Simonsick, E.M.; Kritchevsky, S.B.; Satterfield, S.; Harris, T.B.; Bauer, D.C.; Newman, A.B.; Health, A.B.C.S. Association of a Modified Physiologic Index with mortality and incident disability: The Health, Aging, and Body Composition study. J. Gerontol. A. Biol. Sci. Med. Sci. 2012, 67, 1439–1446. [Google Scholar] [CrossRef] [Green Version]
  11. Whittemore, K.; Vera, E.; Martinez-Nevado, E.; Sanpera, C.; Blasco, M.A. Telomere shortening rate predicts species life span. Proc. Natl. Acad. Sci. USA 2019, 116, 15122–15127. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Codd, V.; Nelson, C.P.; Albrecht, E.; Mangino, M.; Deelen, J.; Buxton, J.L.; Hottenga, J.J.; Fischer, K.; Esko, T.; Surakka, I.; et al. Identification of seven loci affecting mean telomere length and their association with disease. Nat. Genet. 2013, 45, 422–427. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Sanders, J.L.; Newman, A.B. Telomere length in epidemiology: A biomarker of aging, age-related disease, both, or neither? Epidemiol. Rev. 2013, 35, 112–131. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Yakes, F.M.; Van Houten, B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc. Natl. Acad. Sci. USA 1997, 94, 514–519. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Baek, J.H.; Son, H.; Jeong, Y.H.; Park, S.W.; Kim, H.J. Chronological Aging Standard Curves of Telomere Length and Mitochondrial DNA Copy Number in Twelve Tissues of C57BL/6 Male Mouse. Cells 2019, 8, 247. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Lagouge, M.; Larsson, N.G. The role of mitochondrial DNA mutations and free radicals in disease and ageing. J. Intern. Med. 2013, 273, 529–543. [Google Scholar] [CrossRef] [Green Version]
  17. Moore, A.Z.; Ding, J.; Tuke, M.A.; Wood, A.R.; Bandinelli, S.; Frayling, T.M.; Ferrucci, L. Influence of cell distribution and diabetes status on the association between mitochondrial DNA copy number and aging phenotypes in the InCHIANTI study. Aging Cell 2018, 17, e12683. [Google Scholar] [CrossRef] [Green Version]
  18. Kujoth, G.C.; Hiona, A.; Pugh, T.D.; Someya, S.; Panzer, K.; Wohlgemuth, S.E.; Hofer, T.; Seo, A.Y.; Sullivan, R.; Jobling, W.A.; et al. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 2005, 309, 481–484. [Google Scholar] [CrossRef]
  19. Ylikallio, E.; Tyynismaa, H.; Tsutsui, H.; Ide, T.; Suomalainen, A. High mitochondrial DNA copy number has detrimental effects in mice. Hum. Mol. Genet. 2010, 19, 2695–2705. [Google Scholar] [CrossRef] [Green Version]
  20. Jakubowski, H.; Boers, G.H.; Strauss, K.A. Mutations in cystathionine beta-synthase or methylenetetrahydrofolate reductase gene increase N-homocysteinylated protein levels in humans. FASEB J. 2008, 22, 4071–4076. [Google Scholar] [CrossRef]
  21. Chwatko, G.; Boers, G.H.; Strauss, K.A.; Shih, D.M.; Jakubowski, H. Mutations in methylenetetrahydrofolate reductase or cystathionine beta-synthase gene, or a high-methionine diet, increase homocysteine thiolactone levels in humans and mice. FASEB J. 2007, 21, 1707–1713. [Google Scholar] [CrossRef] [PubMed]
  22. Jakubowski, H. Homocysteine in Protein Structure/Function and Human Disease—Chemical Biology of Homocysteine-Containing Proteins; Springer: Wien, Austria, 2013. [Google Scholar]
  23. Jakubowski, H. Homocysteine Modification in Protein Structure/Function and Human Disease. Physiol. Rev. 2019, 99, 555–604. [Google Scholar] [CrossRef] [PubMed]
  24. Mudd, S.H.; Skovby, F.; Levy, H.L.; Pettigrew, K.D.; Wilcken, B.; Pyeritz, R.E.; Andria, G.; Boers, G.H.; Bromberg, I.L.; Cerone, R.; et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am. J. Hum. Genet. 1985, 37, 1–31. [Google Scholar] [PubMed]
  25. Mudd, S.H.; Levy, H.L.; Kraus, J.P. Disorders of transsulfuration. In The Metabolic and Molecular Bases of Inherited Disease, 8th ed.; Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D., Childs, B., Kinzler, K.W., Vogelstein, B., Eds.; Mc Graw-Hill: New York, NY, USA, 2001; Volume 2, pp. 2007–2056. [Google Scholar]
  26. Watanabe, M.; Osada, J.; Aratani, Y.; Kluckman, K.; Reddick, R.; Malinow, M.R.; Maeda, N. Mice deficient in cystathionine beta-synthase: Animal models for mild and severe homocyst(e)inemia. Proc. Natl. Acad. Sci. USA 1995, 92, 1585–1589. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Gupta, S.; Kuhnisch, J.; Mustafa, A.; Lhotak, S.; Schlachterman, A.; Slifker, M.J.; Klein-Szanto, A.; High, K.A.; Austin, R.C.; Kruger, W.D. Mouse models of cystathionine beta-synthase deficiency reveal significant threshold effects of hyperhomocysteinemia. FASEB J. 2009, 23, 883–893. [Google Scholar] [CrossRef] [Green Version]
  28. Jakubowski, H.; Perla-Kajan, J.; Finnell, R.H.; Cabrera, R.M.; Wang, H.; Gupta, S.; Kruger, W.D.; Kraus, J.P.; Shih, D.M. Genetic or nutritional disorders in homocysteine or folate metabolism increase protein N-homocysteinylation in mice. FASEB J. 2009, 23, 1721–1727. [Google Scholar] [CrossRef] [Green Version]
  29. Perla-Kajan, J.; Utyro, O.; Rusek, M.; Malinowska, A.; Sitkiewicz, E.; Jakubowski, H. N-Homocysteinylation impairs collagen cross-linking in cystathionine beta-synthase-deficient mice: A novel mechanism of connective tissue abnormalities. FASEB J. 2016, 30, 3810–3821. [Google Scholar] [CrossRef] [Green Version]
  30. Hernandez-Segura, A.; de Jong, T.V.; Melov, S.; Guryev, V.; Campisi, J.; Demaria, M. Unmasking Transcriptional Heterogeneity in Senescent Cells. Curr. Biol. 2017, 27, 2652–2660.e4. [Google Scholar] [CrossRef] [Green Version]
  31. Sharpless, N.E.; Sherr, C.J. Forging a signature of in vivo senescence. Nat. Rev. Cancer 2015, 15, 397–408. [Google Scholar] [CrossRef]
  32. Guillen, N.; Navarro, M.A.; Arnal, C.; Noone, E.; Arbones-Mainar, J.M.; Acin, S.; Surra, J.C.; Muniesa, P.; Roche, H.M.; Osada, J. Microarray analysis of hepatic gene expression identifies new genes involved in steatotic liver. Physiol. Genomics 2009, 37, 187–198. [Google Scholar] [CrossRef] [Green Version]
  33. Masuyama, M.; Iida, R.; Takatsuka, H.; Yasuda, T.; Matsuki, T. Quantitative change in mitochondrial DNA content in various mouse tissues during aging. Biochim. Biophys. Acta 2005, 1723, 302–308. [Google Scholar] [CrossRef]
  34. Gadaleta, M.N.; Rainaldi, G.; Lezza, A.M.; Milella, F.; Fracasso, F.; Cantatore, P. Mitochondrial DNA copy number and mitochondrial DNA deletion in adult and senescent rats. Mutat. Res. 1992, 275, 181–193. [Google Scholar] [CrossRef]
  35. Fries, G.R.; Bauer, I.E.; Scaini, G.; Wu, M.J.; Kazimi, I.F.; Valvassori, S.S.; Zunta-Soares, G.; Walss-Bass, C.; Soares, J.C.; Quevedo, J. Accelerated epigenetic aging and mitochondrial DNA copy number in bipolar disorder. Transl. Psychiatry 2017, 7, 1283. [Google Scholar] [CrossRef]
  36. Hernandez-Segura, A.; Nehme, J.; Demaria, M. Hallmarks of Cellular Senescence. Trends Cell Biol. 2018, 28, 436–453. [Google Scholar] [CrossRef]
  37. Huang, T.; Rivera-Perez, J.A. Senescence-associated beta-galactosidase activity marks the visceral endoderm of mouse embryos but is not indicative of senescence. Genesis 2014, 52, 300–308. [Google Scholar] [CrossRef] [Green Version]
  38. Khayati, K.; Antikainen, H.; Bonder, E.M.; Weber, G.F.; Kruger, W.D.; Jakubowski, H.; Dobrowolski, R. The amino acid metabolite homocysteine activates mTORC1 to inhibit autophagy and form abnormal proteins in human neurons and mice. FASEB J. 2017, 31, 598–609. [Google Scholar] [CrossRef] [Green Version]
  39. Jakubowski, H. New method for the determination of protein N-linked homocysteine. Anal. Biochem. 2008, 380, 257–261. [Google Scholar] [CrossRef]
  40. Cawthon, R.M. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res. 2009, 37, e21. [Google Scholar] [CrossRef] [Green Version]
  41. Cawthon, R.M. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002, 30, e47. [Google Scholar] [CrossRef]
  42. Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25, 402–408. [Google Scholar] [CrossRef]
  43. Malik, A.N.; Czajka, A.; Cunningham, P. Accurate quantification of mouse mitochondrial DNA without co-amplification of nuclear mitochondrial insertion sequences. Mitochondrion 2016, 29, 59–64. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Box plots illustrating the effects of the Cbs genotype on the expression of senescence-related mRNAs in liver. The following mRNAs were quantified by qPCR in Cbs−/− mice (n = 21) and sex- and age-matched control Cb +/− siblings (n = 22): A. p21, B. Pai-1, C. Mcp-1, D. p16, E. Il-6, and F. Il-1β. Box and whiskers represent the mean ± SEM and the mean ± 95% CI, respectively. Upper and lower p-values refer to data normalized to β-actin (blank boxes) and Gapdh (gray boxes) mRNAs, respectively. NS, not significant.
Figure 1. Box plots illustrating the effects of the Cbs genotype on the expression of senescence-related mRNAs in liver. The following mRNAs were quantified by qPCR in Cbs−/− mice (n = 21) and sex- and age-matched control Cb +/− siblings (n = 22): A. p21, B. Pai-1, C. Mcp-1, D. p16, E. Il-6, and F. Il-1β. Box and whiskers represent the mean ± SEM and the mean ± 95% CI, respectively. Upper and lower p-values refer to data normalized to β-actin (blank boxes) and Gapdh (gray boxes) mRNAs, respectively. NS, not significant.
Ijms 21 02520 g001
Figure 2. Blood telomere length (TL) (A) and plasma total Hcy (tHcy) levels (B) in Cbs−/− and Cbs+/− mice. Blood TL and plasma tHcy were quantified in Cbs−/− mice (n = 40) and sex- and age-matched control Cbs+/− siblings (n = 40) as described in the Materials and Methods. Box and whiskers represent the mean±SEM and the mean ± 95% CI, respectively. Upper and lower p-values refer to data normalized to β-actin (blank boxes) and Gapdh (gray boxes) mRNAs, respectively.
Figure 2. Blood telomere length (TL) (A) and plasma total Hcy (tHcy) levels (B) in Cbs−/− and Cbs+/− mice. Blood TL and plasma tHcy were quantified in Cbs−/− mice (n = 40) and sex- and age-matched control Cbs+/− siblings (n = 40) as described in the Materials and Methods. Box and whiskers represent the mean±SEM and the mean ± 95% CI, respectively. Upper and lower p-values refer to data normalized to β-actin (blank boxes) and Gapdh (gray boxes) mRNAs, respectively.
Ijms 21 02520 g002
Figure 3. Relationships between blood mtDNA copy number and age in female (A) and male (B) Cbs−/− and Cbs+/− mice. ♀ Cbs−/− (n = 11), ♂ Cbs−/− (n = 10), ♀ Cbs+/− (n = 10), and ♂ Cbs+/− (n = 13). Logarithmic trendlines fitted to the data points are shown. rel. = relative.
Figure 3. Relationships between blood mtDNA copy number and age in female (A) and male (B) Cbs−/− and Cbs+/− mice. ♀ Cbs−/− (n = 11), ♂ Cbs−/− (n = 10), ♀ Cbs+/− (n = 10), and ♂ Cbs+/− (n = 13). Logarithmic trendlines fitted to the data points are shown. rel. = relative.
Ijms 21 02520 g003
Table 1. Determinants of blood TL in a combined cohort of Cbs−/− and Cbs+/− mice.
Table 1. Determinants of blood TL in a combined cohort of Cbs−/− and Cbs+/− mice.
VariablePearson CorrelationMultiple Regression
Model 1, HcyModel 2, Cbs Genotype
βpβpβp
Female (n = 39)
Age *0.140.4730.150.4780.100.559
Hcy #0.250.897−0.030.878
Cbs genotype−0.280.884 −0.080.611
F = 0.27, p = 0.768, R2 = 0.02F = 0.36, p = 0.698, R2 = 0.02
Male (n = 41)
Age *−0.560.002−0.500.008−0.380.021
Hcy #−0.340.077−0.160.361
Cbs genotype0.400.033 0.110.493
F = 6.40, p = 0.006, R2 = 0.34F = 4.01, p = 0.027, R2 = 0.18
All (n = 80)
Sex0.070.627 0.030.8160.110.774
Age *−0.280.036−0.240.094−0.1900.102
Hcy #−0.170.203−0.080.553
Cbs genotype0.220.108 0.040.701
F = 1.6, p = 0.195, R2 = 0.08F = 1.6, p = 0.193, R2 = 0.06
* Age varied from 44 to 473 days. # Plasma tHcy varied from 2 to 346 µM.
Table 2. Determinants of TL in mouse blood, brain, and liver: multiple regression analysis.
Table 2. Determinants of TL in mouse blood, brain, and liver: multiple regression analysis.
VariableTL in
BloodBrainLiver
βpβpβp
Female (n = 40)Female (n = 20)
Age *0.100.5590.530.0230.200.392
Cbs genotype−0.080.611−0.100.6410.290.228
F = 0.36, p = 0.698,
R2 = 0.02
F = 3.25, p = 0.066,
R2 = 0.20
F = 1.11, p = 0.351,
R2 = 0.012
Male (n = 41)Male (n = 23)
Age *−0.380.0210.390.078−0.290.181
Cbs genotype0.110.493−0.170.4230.180.417
F = 4.01, p = 0.027,
R2 = 0.18
F = 1.65, p = 0.217,
R2 = 0.14
All (n = 80)All (n = 43)
Sex0.110.774−0.550.0000.480.001
Age *−0.1900.1020.380.003−0.0060.964
Cbs genotype0.040.701−0.120.3400.230.110
F = 1.61, p = 0.193,
R2 = 0.06
F = 9.70, p = 0.000,
R2 = 0.39
F = 4.60, p = 0.008,
R2 = 0.26
* Age varied from 44 to 473 days.
Table 3. Determinants of mtDNA in mouse blood, brain, and liver.
Table 3. Determinants of mtDNA in mouse blood, brain, and liver.
VariableBlood mtDNA
Cbs−/− (n = 40), Cbs+/− (n = 40)
Brain mtDNA
Cbs−/− (n = 19), Cbs+/− (n = 24)
Liver mtDNA
Cbs−/− (n = 19), Cbs+/− (n = 24)
Pearson CorrelationMultiple RegressionPearson CorrelationMultiple RegressionPearson CorrelationMultiple Regression
Model 1, HcyModel 2, Cbs
βpβpβpβpβpβpβp
Females (n = 39)Females (n = 20)Females (n = 20)
Age *−0.010.960−0.050.832−0.290.0900.490.030.490.0320.710.0000.720.000
tHcy #0.080.7030.100.670
Cbs genotype0.020.918 0.090.6000.080.740.100.6270.310.1770.350.030
F = 0.1, p = 0.91, R2= 0.01F = 1.8, p = 0.18, R2 = 0.10 F = 2.2, p = 0.09, R2 = 0.25 F = 14.1, p = 0.000,
R2 = 0.63
Males (n = 41)Males (n = 23)Males (n = 23)
Age *−0.570.005-0.500.023−0.580.0000.490.020.490.0230.600.0030.620.003
tHcy #−0.380.070-0.170.419
Cbs genotype0.500.014 0.270.058−0.110.620.0000.988−0.040.8580.100.580
F = 5.3, p = 0.014, R2 = 0.35F = 13.2, p = 0.000, R2 = 0.48 F =3.28, p = 0.063,
R2 = 0.24
F = 5.9, p = 0.009,
R2 = 0.37
All (n = 80)All (n = 43)All (n = 43)
Sex−0.330.021−0.360.008−0.250.018−0.400.007−0.410.003−0.110.476−0.100.357
Age *−0.320.025−0.330.028−0.450.0000.420.0050.440.0020.670.0000.710.000
tHcy #−0.210.144−0.080.584
Cbs genotype0.290.044 0.180.0880.010.970.020.8600.140.3540.240.041
F = 4.8, p = 0.006, R2 = 0.24F = 9.0, p = 0.000, R2 = 0.29 F = 7.0, p = 0.001,
R2 = 0.35
F = 14.3, p = 0.000,
R2 = 0.44
* Age varied from 44 to 473 days. # Plasma tHcy varied from 2 to 346 µM.
Table 4. Determinants of Pai1, p21, Mcp-1, Il-6, and Kl mRNAs in brains and livers of Cbs−/− and Cbs+/− mice: multiple regression analysis.
Table 4. Determinants of Pai1, p21, Mcp-1, Il-6, and Kl mRNAs in brains and livers of Cbs−/− and Cbs+/− mice: multiple regression analysis.
VariablePai-1 mRNAp21 mRNAMcp-1 mRNAIl-6 mRNAKl mRNA
BrainLiverBrainLiverBrainLiverBrainLiverBrain
βpβpβpβpβpβpβpβpβp
Females (n = 18–20)
Age *−0.150.524−0.210.362 0.140.6210.230.4760.690.001−0.150.497−0.480.043
Cbs gene−0.160.520−0.340.021 −0.660.007 −0.620.006 −0.340.016
TL −0.110.4360.160.536 0.140.609
Tert0.420.1160.710.006−0.100.696 −0.050.8510.150.0060.390.0370.620.0040.170.443
mtDNA−0.210.4190.640.002 0.040.856 0.610.002
NSF = 15.7, p = 0.000, R2 = 0.87NSF = 5.4, p =
0.02, R2 = 0.03
NSF = 4.84, p = 0.015, R2=0.49F = 9.76, p = 0.002, R2=0.57F = 20.0, p =
0.000, R2 = 0.86
F = 3.70, p = 0.047, R2 = 0.32
Males (n = 20–21)
Age *−0.310.207−0.300.327 1.220.0020.520.0050.680.0390.620.015−0.480.060
Cbs gene0.310.207−0.300.139 −0.470.034 −0.440.013 −0.140.321
TL −0.720.002−0.030.880−1.130.003 −1.100.003
Tert 0.760.0200.110.554−0.500.0820.010.960 0.100.645−0.650.0160.180.468
mtDNA 0.360.189 0.730.001
F = 4.7, p = 0.031, R2=0.61F = 4.5, p = 0.020, R2 = 0.35F = 8.78, p = 0.004, R2 = 0.57NSF = 6.17, p = 0.010, R2 = 0.63F = 13.0, p = 0.000, R2 = 0.78F = 5.19, p = 0.016, R2 = 0.56F = 8.9, p =
0.000, R2 = 0.66
NS
All (n = 39–43)
Sex −0.350.044−0.150.2700.460.010
Age * -0.220.140 0.320.0610.430.0020.450.0080.250.093−0.400.011
Cbs gene0.190.270-0.520.001 −0.520.001 −0.430.001 −0.190.112
TL −0.360.028 −0.200.259 −0.280.095
Tert0.150.378 0.0010.993 0.380.019 0.310.044
mtDNA−0.430.018 0.560.000
F = 3.3, p = 0.037, R2 = 0.27F = 7.1, p = 0.003, R2 = 0.29F = 6.0, p = 0.002, R2 = 0.30F = 8.5, p = 0.001, R2 = 0.31F = 3.2, p = 0.036, R2 = 0.23F = 13.5, p = 0.000, R2 = 0.43F = 4.9, p =
0.007, R2 = 0.26
F = 16.9, p =
0.000, R2 = 0.57
F = 8.4, p = 0.001, R2 = 0.34
* Mouse age varied from 44 to 473 days.
Table 5. Determinants of p16 and Il-1β mRNAs in brains and livers of Cbs−/− and Cbs+/− mice: multiple regression analysis.
Table 5. Determinants of p16 and Il-1β mRNAs in brains and livers of Cbs−/− and Cbs+/− mice: multiple regression analysis.
Variablep16 mRNAIl-1β mRNA
BrainLiverBrainLiver
βpβpβpβp
Females (n = 18–20)
Age *0.840.0000.780.0850.300.2140.340.099
Cbs gene0.250.0650.330.0860.140.5610.080.616
TL
Tert −0.070.806−0.180.466−0.380.015
mtDNA 0.630.008
F = 23.8, p = 0.000, R2 = 0.74F = 7.2, p = 0.003,
R2 = 0.59
NSF = 11.8, p = 0.000, R2=0.69
Males (n = 20–21)
Age *0.820.0000.410.0780.460.1420.130.603
Cbs gene−0.050.7140.040.7900.020.939−0.020.876
TL
Tert 0.450.0520.060.8340.080.772
mtDNA 0.650.004
F = 20.7, p = 0.000,
R2 = 0.70
F = 12.4, p = 0.000, R2 = 0.66NSF = 7.5, p = 0.001,
R2 = 0.54
All (n = 39–43)
Sex0.090.014−0.180.180 −0.180.140
Age *0.090.0000.410.058 0.170.392
Cbs gene0.090.1140.150.2780.030.854−0.020.863
TL −0.010.9230.130.419−0.190.184
Tert 0.300.137−0.170.307−0.020.924
mtDNA 0.040.7850.460.0050.700.000
F = 27.8, p = 0.000, R2 = 0.69F = 11.7, p = 0.000,
R2 = 0.56
F = 3.4, p = 0.021,
R2 = 0.31
F = 10.4, p = 0.000,
R2 = 0.64
* Mouse age varied from 44 to 473 days.

Share and Cite

MDPI and ACS Style

Utyro, O.; Perła-Kaján, J.; Jakubowski, H. The Cbs Locus Affects the Expression of Senescence Markers and mtDNA Copy Number, but not Telomere Dynamics in Mice. Int. J. Mol. Sci. 2020, 21, 2520. https://doi.org/10.3390/ijms21072520

AMA Style

Utyro O, Perła-Kaján J, Jakubowski H. The Cbs Locus Affects the Expression of Senescence Markers and mtDNA Copy Number, but not Telomere Dynamics in Mice. International Journal of Molecular Sciences. 2020; 21(7):2520. https://doi.org/10.3390/ijms21072520

Chicago/Turabian Style

Utyro, Olga, Joanna Perła-Kaján, and Hieronim Jakubowski. 2020. "The Cbs Locus Affects the Expression of Senescence Markers and mtDNA Copy Number, but not Telomere Dynamics in Mice" International Journal of Molecular Sciences 21, no. 7: 2520. https://doi.org/10.3390/ijms21072520

APA Style

Utyro, O., Perła-Kaján, J., & Jakubowski, H. (2020). The Cbs Locus Affects the Expression of Senescence Markers and mtDNA Copy Number, but not Telomere Dynamics in Mice. International Journal of Molecular Sciences, 21(7), 2520. https://doi.org/10.3390/ijms21072520

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop